CBDVHS

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCBDVHS
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulatorsCannabinoid CB2 receptor agonistsCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid receptorCannabinoid CB2 receptor
Therapy Area/IndicationsUveitisMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSkye Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesSkye Bioscience Inc
Inactive CompaniesN/A
Active IndicationsUveitisMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A